An iron-based T1 contrast agent made of iron-phosphate complexes:: In vitro and in vivo studies

被引:15
作者
Rodriguez, Elisenda
Simoes, Rui V.
Roig, Anna
Molins, Elies
Nedelko, Nataliya
Slawska-Waniewska, Anna
Aime, Silvio
Arus, Carles
Cabanas, Miquel E.
Sanfeliu, Coral
Cerdan, Sebastian
Garcia-Martin, Maria Luisa
机构
[1] CSIC, ICMAB, Bellaterra 08193, Spain
[2] Univ Coimbra, Ctr Neurociencias & Biol Celular, Coimbra, Portugal
[3] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain
[4] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain
[5] CSIC, IDIBAPS, Inst Invest Biomed Barcelona, Barcelona 08036, Spain
[6] Univ Autonoma Barcelona, Serv RMN, Bellaterra 08193, Spain
[7] Univ Turin, Dipartimento Chim IFM, I-10125 Turin, Italy
[8] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland
关键词
magnetic resonance imaging; T-1 contrast agent; Fe-8; iron phosphate particles; MRI; CLUSTER; GLIOMA; MODEL;
D O I
10.1007/s10334-006-0066-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A new iron-based T, contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe-(phos) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r(1) values to be dependent on the phosphate salt concentration, K2HPO4, present in the medium. r(1) reaches a maximum value of 2.5 mM(-1) s(-1) for measurements carried out at 7 T and 298 K. P-31 MRS, Mossbauer spectroscopy and magnetic measurements of Fe(phos) solutions suggest paramagnetic Fe3+ ions present in the studied iron-phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe-(phos) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T-1 weighted images of brain tumours in mice have shown positive contrast enhancement of Fe-(phos) for tumour afflicted regions in the brain.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [31] Highly Effective T2 MR Contrast Agent Based on Heparinized Superparamagnetic Iron Oxide Nanoparticles
    Lee, Dong Yun
    MACROMOLECULAR RESEARCH, 2011, 19 (08) : 843 - 847
  • [32] Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents
    Das, Soma
    Parga, Kenia
    Chakraborty, Indranil
    Tinoco, Arthur D.
    Delgado, Yamixa
    Lopez, Paola M.
    Vega, Lauren Fernandez
    Sanakis, Yiannis
    Ghosh, Sukhen
    Bankson, Jim
    Klostergaard, Jim
    Gonzalez-Mendez, Ricardo
    Raptis, Raphael G.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2018, 186 : 176 - 186
  • [33] One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo
    Li, Jingjing
    Wu, Chen
    Hou, Pingfu
    Zhang, Min
    Xu, Kai
    BIOSENSORS & BIOELECTRONICS, 2018, 102 : 1 - 8
  • [34] T1-T2 Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
    Szpak, Agnieszka
    Fiejdasz, Sylwia
    Prendota, Witold
    Straczek, Tomasz
    Kapusta, Czeslaw
    Szmyd, Janusz
    Nowakowska, Maria
    Zapotoczny, Szczepan
    JOURNAL OF NANOPARTICLE RESEARCH, 2014, 16 (11)
  • [35] Mn(II) based T1 and T2 potential MRI contrast agent appended with tryptamine: Recognition moiety for Aβ-plaques
    Rastogi, Neeraj
    Tyagi, Nidhi
    Singh, Ovender
    Kumar, B. S. Hemanth
    Singh, Udai P.
    Ghosh, Kaushik
    Roy, Raja
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2017, 177 : 76 - 81
  • [36] Engineered Protein-Driven Synthesis of Tunable Iron Oxide Nanoparticles as T1 and T2 Magnetic Resonance Imaging Contrast Agents
    Aires, Antonio
    Fernandez-Afonso, Yilian
    Guedes, Gabriela
    Guisasola, Eduardo
    Gutierrez, Lucia
    Cortajarena, Aitziber L.
    CHEMISTRY OF MATERIALS, 2022, 34 (24) : 10832 - 10841
  • [37] Macromolecules with Different Charges, Lengths, and Coordination Groups for the Coprecipitation Synthesis of Magnetic Iron Oxide Nanoparticles as T1 MRI Contrast Agents
    Tao, Cheng
    Chen, Yanan
    Wang, Danli
    Cai, Yu
    Zheng, Qiang
    An, Lu
    Lin, Jiaomin
    Tian, Qiwei
    Yang, Shiping
    NANOMATERIALS, 2019, 9 (05)
  • [38] Iron(III)-tCDTA derivatives as MRI contrast agents: Increased T1 relaxivities at higher magnetic field strength and pH sensing
    Xie, Jing
    Haeckel, Akvile
    Hauptmann, Ralf
    Ray, Iweta Pryjomska
    Limberg, Christian
    Kulak, Nora
    Hamm, Bernd
    Schellenberger, Eyk
    MAGNETIC RESONANCE IN MEDICINE, 2021, 85 (06) : 3370 - 3382
  • [39] Lanthanide vanadate-based nanoparticles as multimodal T1 1-T2 T 2 MRI contrast agent and NIR luminescent imaging probe
    Gomez-Gonzalez, Elisabet
    Nunez, Nuria O.
    Caro, Carlos
    Garcia-Martin, Maria L.
    Becerro, Ana I.
    Ocana, Manuel
    JOURNAL OF ALLOYS AND COMPOUNDS, 2024, 1003
  • [40] "Magnus nano-bullets" as T1/T2 based dual-modal for in vitro and in vivo MRI visualization
    Khatik, Renuka
    Wang, Zhengyun
    Li, Fenfen
    Zhi, Debo
    Kiran, Sonia
    Dwivedi, Pankaj
    Xu, Ronald X.
    Liang, Gaolin
    Qiu, Bensheng
    Yang, Qing
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 15 (01) : 264 - 273